|
EP2453927B1
(en)
*
|
2009-07-17 |
2019-05-15 |
Technical University of Denmark |
Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
EP4614148A3
(en)
*
|
2013-03-15 |
2025-12-17 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
JP2014227338A
(ja)
*
|
2013-05-17 |
2014-12-08 |
キヤノン株式会社 |
インドシアニングリーン含有粒子およびその製造方法
|
|
CA2928568A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
SI3138555T1
(sl)
|
2014-04-30 |
2021-06-30 |
Fujifilm Corporation |
Liposomski sestavek in proizvodni postopek zanj
|
|
KR20170132152A
(ko)
*
|
2015-02-13 |
2017-12-01 |
오피 나노 컴퍼니, 리미티드 |
나노입자를 이용한 종양 치료 조성물 및 방법
|
|
EP3265059A4
(en)
|
2015-03-03 |
2018-08-29 |
Cureport Inc. |
Combination liposomal pharmaceutical formulations
|
|
JP2018507227A
(ja)
|
2015-03-03 |
2018-03-15 |
キュアポート インコーポレイテッド |
二薬搭載リポソーム医薬製剤
|
|
EP3270891A1
(en)
*
|
2015-03-17 |
2018-01-24 |
Leon-Nanodrugs GmbH |
Nanoparticles comprising a stabilized boronic acid compound
|
|
US10918599B2
(en)
*
|
2015-04-02 |
2021-02-16 |
The Research Foundation For The State University Of New York |
Serum-stable compositions and methods for light-triggered release of materials
|
|
RS63030B1
(sr)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
|
|
JP6602886B2
(ja)
|
2015-11-02 |
2019-11-06 |
富士フイルム株式会社 |
ゲムシタビンリポソーム組成物を含む腫瘍治療剤およびキット
|
|
US12364661B2
(en)
|
2015-11-20 |
2025-07-22 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
CA3007955A1
(en)
|
2015-12-10 |
2017-06-15 |
Modernatx, Inc. |
Lipid nanoparticles for delivery of therapeutic agents
|
|
JP6721907B2
(ja)
*
|
2015-12-18 |
2020-07-15 |
メディギア・インターナショナル株式会社 |
生体分解性腫瘍封止剤
|
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
|
KR101630397B1
(ko)
*
|
2015-12-31 |
2016-06-24 |
한국과학기술원 |
항암제-인도시아닌 그린-리포좀 복합체를 포함하는 암 치료용 조성물
|
|
WO2017142876A1
(en)
|
2016-02-15 |
2017-08-24 |
University Of Georgia Research Foundation, Inc. |
lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF
|
|
IL263030B2
(en)
|
2016-05-16 |
2024-11-01 |
Access To Advanced Health Inst |
Pegylated liposomes and methods of use
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN106474057A
(zh)
*
|
2016-12-02 |
2017-03-08 |
中国药科大学 |
一种奥沙利铂热敏长循环脂质体的蔗糖溶液制剂及其制备方法
|
|
RU2765736C2
(ru)
*
|
2017-01-18 |
2022-02-02 |
Темасек Лайф Сайенсиз Лаборатори Лимитед |
Гиперстабилизированные липосомы, повышающие направленное таргетирование митотических клеток
|
|
ES3020935T3
(en)
|
2017-03-15 |
2025-05-23 |
Modernatx Inc |
Lipid nanoparticle formulation
|
|
CA3056133A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
KR20190132405A
(ko)
|
2017-03-15 |
2019-11-27 |
모더나티엑스, 인크. |
치료제의 세포내 전달을 위한 화합물 및 조성물
|
|
JP7280624B2
(ja)
|
2017-04-03 |
2023-05-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
経血液脳関門的、経粘膜的及び経皮的薬物送達のための変形可能なナノスケールビヒクル（ｄｎｖ）
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
|
US10925831B2
(en)
*
|
2017-08-28 |
2021-02-23 |
Wake Forest University |
Liposomal formulations of platinum-acridine anticancer agents and methods thereof
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
US11110060B2
(en)
*
|
2017-10-25 |
2021-09-07 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for delivering pharmaceutical agents
|
|
US10606661B2
(en)
*
|
2017-12-15 |
2020-03-31 |
Rubrik, Inc. |
On-demand provisioning of customized developer environments
|
|
EP3731846A4
(en)
|
2017-12-29 |
2022-03-02 |
Wayne State University |
DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF INFECTION
|
|
AU2019288048B2
(en)
|
2018-06-20 |
2022-08-11 |
Fujifilm Corporation |
Combined medicine comprising gemcitabine-encapsulated liposome composition and immune checkpoint blockade
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
AU2019345067A1
(en)
|
2018-09-19 |
2021-04-08 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
EP3890775A1
(en)
*
|
2018-12-06 |
2021-10-13 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic compositions
|
|
RU2706427C1
(ru)
*
|
2018-12-27 |
2019-11-19 |
Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" |
Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата
|
|
MX2021013842A
(es)
*
|
2019-05-14 |
2022-01-18 |
Pharmosa Biopharm Inc |
Composicion farmaceutica de un farmaco de acido debil y metodos de administracion.
|
|
JP7253735B2
(ja)
|
2019-07-02 |
2023-04-07 |
パナソニックＩｐマネジメント株式会社 |
通過可否判定装置、通過管理システム、通過可否判定方法、及び、コンピュータプログラム
|
|
MX2022003269A
(es)
|
2019-09-19 |
2022-07-04 |
Modernatx Inc |
Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos.
|
|
CA3155015A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AU2020349613B2
(en)
|
2019-09-19 |
2025-11-13 |
Danmarks Tekniske Universitet |
Immune stimulating micelle composition
|
|
WO2021062042A1
(en)
*
|
2019-09-24 |
2021-04-01 |
Pataigin, Llc |
Methods for determining growth and response
|
|
CN110571005B
(zh)
*
|
2019-09-27 |
2021-01-01 |
广西科技大学 |
一种固定化金属离子-磁性脂质体及其制备方法和应用
|
|
EP4199906A1
(en)
*
|
2020-08-20 |
2023-06-28 |
Bionanosim (BNS) Ltd |
Lipid delivery systems for delivery of oxaliplatin palmitate acetate
|
|
KR102560135B1
(ko)
|
2020-12-04 |
2023-07-27 |
가톨릭대학교 산학협력단 |
표적 치료제의 효과적인 전달을 위한 다기능성 리포좀 조성물
|
|
US20240229154A9
(en)
|
2021-02-12 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Method for prognosis and treating a patient suffering from cancer
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
MX2023010414A
(es)
|
2021-03-08 |
2023-11-22 |
Eyegene Inc |
Composicion de la vacuna para prevenir el sars-cov-2.
|